Current Pharmaceutical Biotechnology · 2020 · 17 citations · 17 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryOcular Drug DeliveryOphthalmic Drug DeliveryCorneal Drug DeliveryOcular BioavailabilityOcular NanocarriersOcular Penetration EnhancementOphthalmic EmulsionsOphthalmic FormulationsBioavailability Of Ocular DrugsNanoparticle-based Ophthalmic FormulationsNanoparticle-mediated Ocular PenetrationOcular Drug Permeation EnhancementOcular Permeation EnhancementOcular Permeation EnhancersOphthalmic Drug FormulationOphthalmic Formulation Development
BACKGROUND: The present limitations related to the ocular administration of antifungal drugs for the treatment of fungal keratitis include poor ocular bioavailability, limited retention time, and low ocular tissue penetration. METHODS: This study aimed to prepare a novel ophthalmic voriconazole-loaded nanosuspension based on Eudragit RS 100. Pharmasolve® was explored as a corneal permeation enhancer in voriconazole ophthalmic formulation using in vitro and in vivo experiments. Briefly, 1% voriconazole-loaded nanosuspension was prepared using the quasi-emulsion solvent evaporation process. RESULTS: Characterizations of the voriconazole-loaded nanosuspension by Zetasizer Nano ZS and Transmission Electron Microscope (TEM) showed a uniform spherical shape without any agglomeration. The well-discreted nanoparticle with a size of 138 ± 1.3 nm was achieved with high entrapment efficiency (98.6 ± 2.5%) and positive zeta potential in the range of 22.5-31.2mV, indicating excellent physical stability. DISCUSSION: Voriconazole-loaded nanosuspension containing the penetration enhancer displayed good permeability both in vitro and in vivo compared with the commercial voriconazole injection. The voriconazole-loaded nanosuspension exhibited good antifungal activity, significantly inhibiting the growth of Candida albicans at a lower concentration of voriconazole (2.5μg/mL, p < 0.05). CONCLUSION: In conclusion, the voriconazole-loaded nanosuspension containing Pharmasolve® can be used as an effective ophthalmic formulation for the topical ocular delivery of voriconazole.
17
Ameeduzzafar Zafar, Syed Sarim Imam, Syed Nasir Abbas Bukhari et al. · International Journal of Biological Macromolecules · 2017 · 157 citations